Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients. — CFSMEATLAS
Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients.
Nguyen, T, Staines, D, Nilius, B et al. · Biological research · 2016 · DOI
Quick Summary
This study looked at special channels called TRPM3 on immune cells (natural killer cells and B cells) that help control calcium flow inside cells. Researchers found that people with ME/CFS have fewer of these channels on certain immune cells and problems with calcium movement compared to healthy people. This suggests that broken calcium control in immune cells might play a role in ME/CFS, though much more research is needed to understand what this means for the illness.
Why It Matters
This is the first study to identify and characterize TRPM3 channels on immune cells in ME/CFS, opening a new avenue for understanding immune dysfunction in the disease. Since calcium signaling is critical for immune cell function, defects in this pathway could help explain why ME/CFS patients have persistent immune abnormalities and poor immune responses.
Observed Findings
TRPM3 surface expression identified on NK and B lymphocytes in healthy controls for the first time.
Significant reduction in TRPM3 expression on CD19(+) B cells in ME/CFS patients compared to healthy controls.
Significant reduction in TRPM3 expression on CD56(bright) NK cells in ME/CFS patients compared to healthy controls.
Decreased cytoplasmic calcium ion concentration in CD19(+) B lymphocytes from ME/CFS patients under stimulation.
Decreased cytoplasmic calcium in CD56(bright) NK cells from ME/CFS patients in the presence of thapsigargin and 2-APB.
Inferred Conclusions
TRPM3 channels play a previously unrecognized role in NK and B cell biology.
ME/CFS patients show impaired TRPM3-mediated calcium signaling in specific immune cell populations.
IMPaired calcium mobilization in immune cells may contribute to immune dysfunction in ME/CFS and warrants further investigation.
Remaining Questions
Do genetic polymorphisms in TRPM3 genes directly cause the reduced TRPM3 expression observed in ME/CFS patients?
Does reduced TRPM3 expression actually impair immune function, and does this correlate with disease severity or specific clinical symptoms?
What This Study Does Not Prove
This study does not prove that TRPM3 deficiency causes ME/CFS, only that it is associated with the disease. It does not establish whether reduced TRPM3 is a primary cause, a consequence of illness, or a marker of something else going wrong. The findings need replication in larger studies and functional validation to understand clinical relevance.